Subramenium GA, Sabui S, Marchant JS, Said HM, Subramanian VS. Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-B-mediated pathway. Vitamin C is an antioxidant and acts as a cofactor for many enzymatic reactions. Humans obtain vitamin C from dietary sources via intestinal absorption, a process that involves the sodiumdependent vitamin C transporters-1 and -2 (SVCT1 and SVCT2). Enterotoxigenic Escherichia coli (ETEC) infection impacts intestinal absorption/secretory functions, but nothing is known about its effect on ascorbic acid (AA) uptake. Here we demonstrate that infection of Caco-2 cells with ETEC led to a significant inhibition in intestinal AA uptake. This inhibition was associated with a marked reduction in hSVCT1 and hSVCT2 protein, mRNA, and heterogeneous nuclear RNA (hnRNA) expression levels as well as significant inhibition in the activity of both the SLC23A1 and SLC23A2 promoters. Similarly, exposure of mice to ETEC led to a significant inhibition in intestinal AA uptake and reduction in mSVCT1 and mSVCT2 protein, mRNA, and hnRNA expression levels. Inhibition was caused by the action of heat labile enterotoxin (LT), since infecting Caco-2 cells with LTdeficient ETEC (⌬LT) failed to impact AA uptake. Because LT activates adenylate cyclase, we also examined the effect of dibutyryl-cAMP in AA uptake by Caco-2 cells and observed a significant inhibition. Furthermore, treating the cells with celastrol, a specific NF-B inhibitor, significantly blocked the inhibition of AA uptake caused by ETEC infection. Together, these data demonstrate that ETEC infection impairs intestinal AA uptake through a cAMPdependent NF-B-mediated pathway that regulates both SLC23A1 and SLC23A2 transcription.
INTRODUCTION
Ascorbic acid (AA; vitamin C) plays many important roles in cellular homeostasis. It is an antioxidant, protecting impor-tant biomolecules (DNA, proteins, and lipids) from reactive oxygen species and oxidative stress (28) . AA also acts as a cofactor for many essential enzymatic reactions (28) . Optimal vitamin C levels also protect against disease conditions such as osteoporosis, cancer, cataract formation, and hepatic and cardiovascular ailments (7, 21, 33) . Vitamin C deficiency is associated with impaired immune function, including delayed killing of bacteria by natural killer cells and suppressed cytotoxic T cell function (8) . Humans lack L-gulono-␥-lactone oxidase (Gulo), an enzyme involved in the terminal step of L-AA biosynthesis incapable of synthesizing vitamin C endogenously (27) . Therefore, vitamin C must be obtained from dietary sources, and is transported into intestinal epithelial cells through a sodium-dependent carrier-mediated process involving two sodium-dependent vitamin C transporters (SVCT1 and SVCT2, products of the SLC23A1 and SLC23A2 genes, respectively) (12, 22, 29, 32) . The transport proteins of human and mouse origin share significant sequence homology (32) . SVCT1 and SVCT2 are expressed at the apical and basolateral membrane domains of the polarized intestinal epithelial cells (6, 35) and show differential expression patterns along the intestinal tract (37) .
Enterotoxigenic Escherichia coli (ETEC), a causative agent of infectious diarrhea, remains a leading cause of mortality and morbidity across the world (1, 3, 5) . ETEC represents a heterogeneous group of pathogenic bacteria that colonize in the small intestine and lead to acute secretory diarrhea with abdominal cramps and is usually self-limited (2, 20, 40, 45) . The duration and severity of ETEC infection has been reported to be dependent on host factors (45) . Repeated bouts of infection with ETEC and prolonged dual infections with other enteric pathogens may negatively impact the nutritional status of the host (especially those who are already nutritionally compromised), thus impacting growth and development (9, 24, 42) . ETEC causes pathology through the production of enterotoxins, including the heat labile (LT) and heat stable toxins (ST), which induces loss of water and electrolytes from the intestine of the infected individuals (41) . The LT is structurally and functionally related to cholera toxin, and LT activates adenylate cyclase, which leads to an increase the production of intracellular cAMP (25, 26, 34) . This then leads to activation of downstream targets like protein kinase A (PKA) (26, 34) and the nuclear factor--light chain enhancer of activated B cells (NF-B) in intestinal epithelial cells (43, 44) .
Although infection with ETEC is well known to affect absorption and secretion in the intestine (9, 17, 18) , nothing is currently known about the impact of ETEC on intestinal absorption of vitamin C, which is the focus of this investigation. Furthermore, studies that aim at improving knowledge and understanding of the cellular and molecular mechanism(s) involved in maintaining and regulating vitamin C body homeostasis is important, especially in conditions of deficiency/ suboptimal levels. In this study, we employed in vitro (human intestinal Caco-2 cells) and an in vivo Gulo knockout mice experimental models. Our findings demonstrate that the LT produced by ETEC inhibits intestinal AA uptake, and this effect is mediated, at least in part, via transcriptional repression of both the SLC23A1 and SLC23A2 genes through a cAMPdependent NF-B signaling pathway.
MATERIALS AND METHODS

Materials
Bacterial strains. Wild-type ETEC strain H10407 (ATCC, Manassas, VA) and mutant ⌬ eltA H10407 [⌬LT; a kind gift from Dr. J. M.
Fleckenstein, Washington University School of Medicine, St. Louis, MO (13) ] were grown in Luria-Bertani (LB) broth and maintained in LB agar plates.
Chemicals and antibodies. [ 14 C]AA (specific activity~2.8 mCi/ mmol) was purchased from PerkinElmer (Boston, MA). The anti-hSVCT1 antibody was from Santa Cruz Biotechnology (Cat No. Sc 376090, Santa Cruz, CA), anti-SVCT2 antibody was from Novus Biologicals (Cat No. NBP2-57176, Littleton, CO), anti-mSVCT1 antibody was from EpiGentek (Cat No. A60934, Farmingdale, NY), and ␤-actin antibodies were from Santa Cruz Biotechnology (Cat Nos. Sc 47778 and Sc130656). The anti-rabbit IRDye-800, anti-mouse IRDye-800, anti-mouse IRDye-680, and anti-goat IRDye-680 secondary antibodies were obtained from LI-COR Biosciences (Lincoln, NE). All of the other reagents and chemicals used in this study were of molecular biology grade and purchased from various commercial vendors. Primers used were synthesized using Sigma Genosys (Woodlands, TX).
Methods
Culturing of Caco-2 cells and ETEC treatment.
Human-derived intestinal epithelial Caco-2 cells (ATCC) (derived from a 72-yr-old adult male) were maintained in Eagle's minimal essential medium (EMEM; Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum and antibiotics at 37°C in a 5% CO 2 incubator. Caco-2 cells were infected with ETEC as described previously (17) with minor modifications. Briefly, Caco-2 cell monolayers (3-4 days postconfluence; differentiated) were incubated with antibiotic-and serum-free EMEM 12 h before bacterial infection. To prepare bacteria stocks for infection, overnight cultures of either ETEC (wild type) or the ETEC ⌬LT mutant strain were diluted to 1:50 in LB broth and allowed to grow for 3 h (to achieve logarithmic growth phase), after which optical density (OD 600) was measured. Bacteria were harvested and resuspended in serum, and antibiotic-free EMEM at a final concentration of 10 multiplicity of infection (MOI). The culture supernatant was collected after 16 h of ETEC culture and then centrifuged and filtered (0.45-m sterile syringe filter). To prepare heat-killed (boiled) bacteria and boiled supernatant, the 16-h grown ETEC and culture supernatant were boiled in a water bath at 100°C for 30 min (10). Caco-2 cell monolayers were exposed to 10 MOI ETEC, boiled ETEC (heat-killed), or ETEC ⌬LT suspended in serum-and antibiotic-free EMEM or 20% of ETEC culture supernatant or boiled culture supernatant in serum-and antibiotic-free EMEM for 5 h, after which the medium was replaced with serum-free medium containing 50 g/ml gentamycin for 1 h. The medium was then replaced with serum-and antibiotic-free EMEM, and the cells were incubated at 37°C in a CO 2 incubator for 12 h to see the postinfection effect. ETEC-infected Caco-2 cells were then used for further analysis. Infection of mice with ETEC. Mice were infected with ETEC as previously described (2) with only slight modifications. Briefly, Gulo knockout (KO) Swiss mice (BALB/c) weighing ϳ25 g (8-to 10-wkold male mice) were introduced in sterile microisolator cages containing autoclaved bedding and drinking water. To eradicate commensal microflora from the intestinal tract, mice received streptomycin (5 g/l) in their drinking water for 48 h before ETEC infection. Fructose (6.7%) was added to the drinking water to encourage fluid intake. Food was withdrawn (12 h before), and sterile water was provided 4 h before ETEC inoculation. Cimetidine (50 mg/kg) was administered intraperitoneally to all mice 2 h before inoculation with ETEC to minimize stomach acidity. Each mouse was orally inoculated with ETEC suspension (~4 ϫ 10 8 colony-forming units/mice, 200 l) using a 20-gauge gavage needle. Control mice were gavaged with the same volume of PBS. Inoculated mice were monitored for 24 h, and then tissue was harvested for experimental studies. For RNA and protein analysis, jejunum mucosa was separated and frozen in liquid nitrogen for further analysis. All animal studies described in this research work were approved by the Institutional Animal Care and Use Committee of the Veteran Affairs Medical Center (Long Beach, CA).
AA uptake in Caco-2 cells (in vitro model) and closed loop mice jejunum (in vivo model). [ 14 C]AA uptake studies using ETEC-infected confluent monolayers of Caco-2 cells were performed as previously described (37) . Briefly, cells were washed two times with Krebs-Ringer (KR) buffer and incubated for 30 min (KR buffer 37°C) in the presence of labeled AA (0.4 Ci/ml). Specific uptake was determined by comparison with cells incubated with [ 14 C]AA and excess (1 mM) unlabeled AA. At the end of the incubation period, buffer was aspirated, and cells were washed two times with ice-cold KR buffer and lysed with NaOH (followed by neutralization with HCl). Samples were counted for radioactivity content using a liquid scintillation counter (Beckman Coulter, Brea, CA). For tissue uptake studies, intact intestinal loops (~1 cm) were made in the jejunal area (36) and filled with 100 l of KR buffer containing labeled or labeled plus unlabeled 1 mM AA, and uptake was performed for 7 min before washing, tissue lysing, and liquid scintillation counting. The protein content of the digested samples was determined using a Bio-Rad protein assay kit. Real-time PCR. Total RNA was isolated (either from Caco-2 cells or mice jejunal mucosa) using TRIzol reagent (Invitrogen, Carlsbad, CA). Samples were treated with DNase I to remove DNA contamination. RNA samples were then reverse transcribed to cDNA using the iScript cDNA kit (Bio-Rad, Hercules, CA) for quantitative realtime PCR (RT-qPCR) analysis using gene-specific primers (Table 1) in a CFX96 real-time system, C1000 touch thermal cycler (Bio-Rad). For heterogeneous nuclear RNA (hnRNA) analysis, SLC23A1 and SLC23A2 gene-specific hnRNA primers (Table 1 ) and a negative control were run in the absence of cDNA template to determine the specific amplification. RT-qPCR data were normalized to ␤-actin hnRNA primers. The qPCR was performed at the following conditions: initial denaturation at 95°C for 5 min, 45 cycles of 95°C with a 30-s hold, and 55°C with 15 s hold followed by 72°C with 30-s hold for extension and fluorescence measurement. Relative expression of different mRNAs was normalized relative to ␤-actin as an internal control and quantified by the ⌬⌬C t method (23) .
Transfection of Caco-2 cells and promoter analysis. Caco-2 cells were grown in 12-well cell culture plates (Corning, NY) and cotransfected using Lipofectamine 2000 (Invitrogen) at 80 -90% confluence with Renilla luciferase-thymidine kinase (pRL-TK) and 3 g of SLC23A1 or SLC23A2 promoter constructs or pGL3 basic vector alone. After 24-h transfection, the cells were infected with ETEC as stated above, and luciferase activity was measured after cell lysis. Firefly luciferase readings were normalized against Renilla luciferase expression (Promega, Madison, WI).
Western blot analysis. Caco-2 cell monolayers and mouse jejunal mucosa were lysed in radioimmunoprecipitation assay buffer (Sigma) in the presence of complete protease inhibitor cocktail (Roche, Nutley, NJ). The soluble fraction was isolated by centrifugation (14,000 g for 30 min), and protein content was measured using a protein assay kit (Bio-Rad). An equal amount of protein (60 g) was loaded on a 4 -12% gradient mini gel (Invitrogen) and transferred to a polyvinylidene difluoride membrane for Western blot analysis. The membrane was blocked overnight and probed with primary antibodies [hSVCT1 (1:200 dilution), mSVCT1 (1:500 dilution), h-or mSVCT2 (1:200 dilution)] and secondary antibodies (1: 30,000 dilutions; LI-COR Biosciences) as described previously (37, 38) . The specificity of these antibodies has been previously shown in various in vitro and in vivo preparations (37, 38) . An anti-␤-actin antibody (1:3,000 dilution) was used as a normalization control. Relative protein expression of the specific band was quantified by normalizing the signal intensity against the ␤-actin band using the Odyssey Infrared imaging suite (version 3; LI-COR Biosciences).
Drug treatment of Caco-2 cells. Caco-2 cell monolayers were pretreated with either 3=,5=-dideoxyadenosine (DDA; adenylate cyclase inhibitor; 100 M for 1 h), N- [2-(p-bromocinnamylamino) ethyl]-5-iso quinoline sulfonamide dihydrochloride [H-89 (Sigma); PKA inhibitor; 0.5 mM for 1 h], or celastrol (100 nM for 5 h; InvivoGen, San Diego, CA) in serum-and antibiotic-free EMEM before ETEC infection. Caco-2 cell monolayers were treated with dibutyryl-cyclic adenosine monophosphate [dbcAMP (Sigma); a cellpermeable cAMP (1 mM)] alone in serum-and antibiotic-free EMEM. Different drug-treated Caco-2 cell monolayers were assessed for [ 14 C]AA uptake as described above. 
Statistical Analysis
Uptake data represent means Ϯ SE of multiple separate experimental determinations and are expressed as a percentage of simultaneously performed controls. AA uptake by the carrier-mediated process was determined by subtracting uptake of [ 14 C]AA in the presence of 1 mM of unlabeled AA from uptake in its absence. Student's t-test was used for statistical analysis with P Ͻ 0.05 considered statistically significant. All experimental parameters were determined from at least three independent sample preparations.
RESULTS
Effect of ETEC on Intestinal AA Uptake by Caco-2 Cells
First, we examined the effect of ETEC (10 MOI) infection on carrier-mediated [ 14 C]AA uptake in an in vitro model. Uptake studies were performed using confluent Caco-2 cell monolayers after 5 h of infection with ETEC followed by 12-h postinfection as described in Methods. Under these conditions, ETEC infection led to a significant inhibition in AA (~60%, P Ͻ 0.01) uptake compared with unexposed control Caco-2 cells (Fig. 1A) . Carrier-mediated 14 C-AA uptake by Caco-2 cells was also assessed after infection with boiled ETEC samples (heat killed), ETEC culture supernatant, and boiled culture supernatant. These manipulations were performed to assess whether secreted toxins (LT and/or ST) were responsible for the observed inhibition. [ 14 C]AA uptake by Caco-2 cells was not inhibited by boiled ETEC or boiled ETEC culture supernatant, whereas a significant inhibition (~45%, P Ͻ 0.05) was observed in the presence of ETEC culture supernatant (Fig. 1A) . The inability of boiled ETEC and boiled ETEC culture supernatant to inhibit [ 14 C]AA uptake suggested that the LT secreted by ETEC could be responsible for the observed AA uptake inhibition. To directly assess the role of LT in AA uptake inhibition, Caco-2 cells were infected with ETEC ⌬LT (⌬eltA H10407; a mutant lacking LT production but competent to secrete ST). ETEC ⌬LT did not inhibit [ 14 C]AA uptake compared with uninfected control cells (Fig. 1B) . Together, these findings suggest that LT produced by ETEC inhibits the AA uptake in Caco-2 cells. 
Effect of ETEC on Intestinal AA Transporter Expression by Caco-2 Cells
Next, we also determined the effect of ETEC infection of Caco-2 cells on the protein and mRNA expression levels of AA transporters (hSVCT1 and hSVCT2). Results showed a significant (P Ͻ 0.05 and P Ͻ 0.01 for hSVCT1 and hSVCT2, respectively) reduction in the expression level of both hSVCT1 and hSVCT2 proteins compared with control (Fig. 2, A and B) . On the other hand, no significant reduction in the protein expression level of hSVCT1 and hSVCT2 was observed upon infection with ETEC ⌬LT compared with uninfected control cells. Similarly, a marked decrease in hSVCT1 (~70%) and hSVCT2 (~49%) mRNA expression levels (P Ͻ 0.01 for both) was observed upon ETEC treatment in Caco-2 cells, and no effect was observed upon ETEC ⌬LT treatment compared with uninfected controls (Fig. 2, C and D) . The changes in mRNA expression level upon ETEC infection are an indication of changed transcription of the involved genes. Therefore, we subsequently determined the level of expression of hSVCT1 and hSVCT2 hnRNA (the first product of transcription of a given gene that reflects its rate of transcription) (14) in ETECinfected Caco-2 cells. The results showed that ETEC treatment markedly decreased the expression of hSVCT1 and hSVCT2 (P Ͻ 0.01 for both) hnRNA compared with untreated controls (Fig. 3, A and B) . On the other hand, ETEC ⌬LT infection did not affect the hSVCT1 and hSVCT2 hnRNA expression levels compared with uninfected controls (Fig. 3, A and B) .
To further assess the role of transcriptional mechanism(s) in the effect of ETEC on hSVCT1 and hSVCT2 expression, we examined the effect of the pathogen on the activity of the SLC23A1 and SLC23A2 promoters following their transfection in Caco-2 cells (30, 31) . ETEC infection significantly (P Ͻ 0.01 for both) inhibited the activity of both SLC23A1 and SLC23A2 promoters by~32% and~38%, respectively, compared with uninfected controls. In addition, ETEC ⌬LT-infected Caco-2 cells did not affect the activity of SLC23A1 and SLC23A2 promoters when compared with uninfected controls (Fig. 3, C and D) .
Effect of ETEC Infection on Intestinal AA Uptake In Vivo
To examine the effect of ETEC infection in vivo, we gavaged Gulo KO mice with ETEC and performed AA uptake analysis after 24 h. The results showed a significant (P Ͻ 0.05) inhibition in intestinal AA uptake of ETEC-infected mice compared with age-and sex-matched control Gulo KO mice (Fig. 4) . This inhibition was associated with a significant decrease in the intestinal mSVCT1 (P Ͻ 0.01) and mSVCT2 (P Ͻ 0.05) protein expression levels (Fig. 5, A and B) . In parallel, mRNA (Fig. 6, A and B) and hnRNA (Fig. 6 , C and D) expression levels of intestinal mSVCT1 and mSVCT2 were also significantly (P Ͻ 0.05 for mSVCT1 mRNA and hnRNA and mSVCT2 hnRNA; P Ͻ 0.01 for mSVCT2 mRNA) decreased in ETEC-infected mice compared with their respective control. 
Role of cAMP-Mediated NF-B Signaling Pathway in the Inhibitory Effect of ETEC Infection on AA Uptake
Previous studies have shown that LT activates adenylate cyclase, which leads to an increase in intracellular cAMP level (44) . Therefore, to determine if the elevated level of cAMP mediates the observed inhibition of AA uptake, Caco-2 cells were treated with dbcAMP (a cell-permeable cAMP; 1 mM) to increase intracellular cAMP. Caco-2 cells were separately treated with ETEC in the presence of DDA (adenylate cyclase inhibitor that inhibits cAMP production; 100 M). The results showed a significant (P Ͻ 0.05) inhibition in AA uptake in the cells treated with dbcAMP compared with untreated controls, whereas DDA significantly (P Ͻ 0.01) blocked the inhibitory effect in cells treated with ETEC and DDA together compared with either dbcAMP-or ETEC alone-treated Caco-2 cells (Fig.  7) . These findings suggest that cAMP signaling transduces the inhibitory effect of ETEC on AA uptake in Caco-2 cells.
Elevated levels of cAMP activate both PKA-and NF-B (PKA-independent mechanism)-mediated signaling pathways (43, 44) . To determine the contribution of these signaling pathways to the inhibitory effects of ETEC on AA uptake, we pretreated Caco-2 cells with either H-89 (a PKA inhibitor) or celastrol (an NF-B inhibitor) before exposure of ETEC, followed by determination of AA uptake. Results showed the inability of H-89 to prevent the ETEC-mediated inhibition in AA uptake (Fig. 8 ). On the other hand, the inhibition of AA uptake was significantly (P Ͻ 0.05) blocked upon treatment with celastrol and ETEC together (Fig. 8) . Collectively, these results suggest that the LT secreted by ETEC elevates the level of cAMP and activates the NF-B signaling pathway, ultimately inhibiting intestinal AA uptake.
DISCUSSION
ETEC is a clinically important enteric pathogen that is a major cause of acute secretory diarrhea worldwide. There are over 400 million cases of ETEC-related diarrheal disease reported annually, resulting in significant morbidity and mortality, including over 380,000 deaths annually among children below 5 yr of age (39) . Furthermore, repeated bouts of infection with ETEC and prolonged dual infections with other enteric pathogens may affect the nutritional status of the host (9, 24, 42) . ETEC produces enterotoxins, which aid in its adherence to the host intestine and pathogenesis of its pathological effects on intestinal physiology (15, 20) . Although ETEC has been shown to affect intestinal transport of many substrates, including water-soluble vitamins (4, 17, 19, 46) , to date, nothing is known about the effect of ETEC on intestinal AA uptake or molecular mechanism(s) involved. Thus, the current study was aimed to address these issues using an in vitro and in vivo experimental models. Outcome of this study, at least in part, ultimately will help in designing effective strategies to optimize normal vitamin C body homeostasis, especially in conditions associated with deficiency/suboptimal levels due to prolonged diarrheal illness upon enteric pathogen infection.
Our in vitro experiments showed that ETEC, or ETEC culture supernatant, caused a significant inhibition in carriermediated intestinal AA uptake. This inhibition was mediated by LT, since exposure of Caco-2 cells with supernatant, but not 
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EFFECT OF ETEC ON INTESTINAL VITAMIN C TRANSPORT boiled ETEC supernatant, mimicked the inhibitory effect on AA uptake. A role for the LT in mediating the inhibitory effect of ETEC on AA uptake was implicated from our studies using ETEC ⌬LT, which lacks an ability to produce LT. The effect of LT on AA uptake was associated with decreased expression of the hSVCT1 and hSVCT2 protein, and changes in mRNA, and hnRNA expression, suggesting the involvement of transcriptional mechanism(s). Indeed, upon examining the effect of ETEC on activity of the SLC23A1 and SLC23A2 promoters transfected in Caco-2 cells, significant inhibition was observed in the activity of both promoters. Similar findings were observed in vivo where ETEC infection of the Gulo KO mice was found to lead to a significant inhibition in AA uptake and expression of the intestinal mSVCT1 and mSVCT2 protein, mRNA, and hnRNA. Together these findings suggest that the inhibitory effect on AA uptake upon ETEC infection is due to LT and is mediated at least in part at the level of transcription of both the SLC23A1 and SLC23A2 genes. LT is structurally and functionally similar to cholera toxin (produced by Vibrio cholera), which acts through dysregulation of intracellular cAMP levels (11, 25, 44) . Studies have shown that expression of hSVCT1 in patients infected with V. cholera is also markedly reduced (16) . In our studies, the observed inhibition of AA uptake by ETEC-secreted LT is likely mediated via cAMP through changes in activities of both the PKA and NF-B pathways (44) . However, our study indicates that its effect on AA uptake physiology appears to be transduced through the NF-B-mediated signaling pathway rather than the PKA-mediated pathway. This observation is based on our findings that treating Caco-2 cells with celastrol (an inhibitor of NF-B) blocked the inhibitory effect of LT on AA uptake, whereas treatment with H-89 (an inhibitor of PKA) did not. In summary, these findings demonstrate that the LT produced by ETEC inhibits intestinal AA uptake, and this effect is mediated, at least in part, via transcriptional repression of both the SLC23A1 and SLC23A2 genes via a cAMPdependent NF-B-mediated intracellular signaling pathway. 
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